Cross-fund · 4 holders
SABS
SAB BIOTHERAPEUTICS INC
CUSIP 78397T103 / 78397T202
4
Tracked holders
$19.9M
Aggregate value
5,250,759
Shares
4
Active funds
Funds holding SABS
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Millennium | Multi-Strategy | Q1 2026 | $11.6M | — | +2,708,607 | +835.8% |
| Vanguard | Institutional | Q4 2025 | $6.9M | — | +1,481,383 | +405.0% |
| BlackRock | Institutional | Q1 2026 | $1.2M | — | +284,087 | +1647.9% |
| Citadel | Multi-Strategy | Q1 2026 | $266,568 | — | +51,950 | +294.3% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.